-
公开(公告)号:EP4403186A1
公开(公告)日:2024-07-24
申请号:EP22870048.0
申请日:2022-09-16
申请人: Keio University
发明人: YASUDA Hiroyuki , SATO Toshiro , EBISUDANI Toshiki , FUKUSHIMA Takahiro , FUKUNAGA Koichi , HAMAMOTO Junko
IPC分类号: A61K45/00 , A61P11/00 , A61P35/00 , C12N5/09 , C12N1/00 , G01N33/574 , A61K31/4985
CPC分类号: A61K31/4985 , A61K45/00 , A61P11/00 , A61P35/00 , C12N1/00 , C12N5/06 , G01N33/574
摘要: A therapeutic agent for small cell lung cancer containing an insulin-like growth factor 1 receptor (IGF1R) inhibitor as an active ingredient, and a method whether or not an administration of the therapeutic agent for small cell lung cancer patients is effective, including: a step of detecting the expression of YAP1 or its downstream factors in the cancer cells from the small cell lung cancer patient; and a step of detecting the expression of YAP1 or its downstream factors in the cancer cells from the small cell lung cancer patient, wherein when the expression level of YAP1 or the expression level of the downstream factor of YAP1 is significantly higher than that of a control, the administration of the therapeutic agent is effective in treating the patient with small cell lung cancer.
-
公开(公告)号:EP3831292B1
公开(公告)日:2024-07-24
申请号:EP18842628.2
申请日:2018-11-16
CPC分类号: A61B5/125 , A61B5/0051 , A61B5/6867 , A61B5/1104
-
公开(公告)号:EP3692813B1
公开(公告)日:2023-12-13
申请号:EP18864057.7
申请日:2018-09-25
发明人: FUKUDA, Shinji , KANO, Chie , MORITA, Hiroto
-
4.
公开(公告)号:EP3505620B1
公开(公告)日:2023-07-26
申请号:EP17843522.8
申请日:2017-08-21
发明人: SATO, Toshiro , KATAYAMA, Kazuhiko
-
公开(公告)号:EP3269344B1
公开(公告)日:2022-08-10
申请号:EP16764474.9
申请日:2016-03-14
-
公开(公告)号:EP3421598B1
公开(公告)日:2021-07-14
申请号:EP17744467.6
申请日:2017-01-31
发明人: KO, Minoru
IPC分类号: A61P15/00 , A61K31/4709 , A61K31/55 , A61P43/00
-
公开(公告)号:EP3741844A1
公开(公告)日:2020-11-25
申请号:EP19741620.9
申请日:2019-01-16
申请人: Keio University
发明人: SHIMMURA, Shigeto , HATOU, Shin , TSUBOTA, Kazuo
IPC分类号: C12N5/0793 , A61K35/30 , A61L27/38 , A61P27/02 , C12N5/00 , C12N5/0735 , C12N5/10
摘要: Using the medium of the present invention for inducing a cornea endothelial substitute cell from an iPS cell, the medium containing an insulin-like growth factor and a STAT3 activator, and not containing a basic fibroblast growth factor or a ROCK inhibitor, and the method of the present invention for inducing corneal endothelial substitute cells from iPS cells by using the medium, it becomes possible to efficiently produce corneal endothelial substitute cells, particularly to efficiently produce corneal endothelial substitute cells from iPS cells. Furthermore, it becomes possible to stably produce large amounts of corneal endothelial substitute cells by inducing differentiation of iPS cells into corneal endothelial substitute cells more efficiently.
-
8.
公开(公告)号:EP3698712A1
公开(公告)日:2020-08-26
申请号:EP18868564.8
申请日:2018-10-19
发明人: USHIBA, Junichi , MORIKAWA, Koji
IPC分类号: A61B5/0476 , A61H1/02 , G06F3/01
摘要: An object is to improve the decision accuracy of electroencephalograms. An electroencephalogram decision system (10) determines, when finding electroencephalogram information representing an electroencephalogram obtained by an electrode unit (11) placed on a region of interest that forms part of a subject's (5) head (52) satisfying a predetermined condition, that a target electroencephalogram, which is an electroencephalogram with a characteristic variation, should have been produced. The predetermined condition is selected from a plurality of detection conditions including a first type of condition and a second type of condition. The first type of condition specifies that a decision should be made, based on a component falling within a single frequency band included in the electroencephalogram represented by the electroencephalogram information, whether or not the target electroencephalogram has been produced. The second type of condition specifies that a decision should be made, based on components falling within multiple different frequency bands included in the electroencephalogram represented by the electroencephalogram information, whether or not the target electroencephalogram has been produced.
-
9.
公开(公告)号:EP3694883A1
公开(公告)日:2020-08-19
申请号:EP18796140.4
申请日:2018-10-12
申请人: Keio University
发明人: CHIKUMA, Mariko , YASUI, Masato
IPC分类号: C07K16/28
-
公开(公告)号:EP3692990A1
公开(公告)日:2020-08-12
申请号:EP18864483.5
申请日:2018-10-02
申请人: Keio University , Pola Pharma Inc.
IPC分类号: A61K31/4168 , A61K31/4172 , A61P35/00 , A61P35/04 , C07D233/91
摘要: The object of the present invention is to provide a novel pharmaceutical for suppressing cancer stem cells. In the present invention, a mitochondria inhibitor comprising a 2-nitroimidazole derivative is applied to the cancer stem cell as an active ingredient.
-
-
-
-
-
-
-
-
-